Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Yeast, Unspecified is a multifaceted biological agent used in allergenic extracts for diagnosis and immunotherapy, as well as a source of essential B-complex vitamins. It belongs to the standardized and non-standardized chemical allergen classes.
Name
Yeast, Unspecified
Raw Name
YEAST, UNSPECIFIED
Category
Standardized Chemical Allergen [EPC]
Drug Count
8
Variant Count
8
Last Verified
February 17, 2026
About Yeast, Unspecified
Yeast, Unspecified is a multifaceted biological agent used in allergenic extracts for diagnosis and immunotherapy, as well as a source of essential B-complex vitamins. It belongs to the standardized and non-standardized chemical allergen classes.
Detailed information about Yeast, Unspecified
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Yeast, Unspecified.
Yeast, Unspecified is a comprehensive pharmacological designation used to describe biological substances derived from various yeast species, most commonly belonging to the Saccharomyces or Candida genera, which have not been further specified to a single species in a clinical or manufacturing context. In the realm of clinical pharmacology, Yeast, Unspecified belongs to a diverse class of drugs called Standardized and Non-Standardized Chemical Allergens [EPC], as well as being a primary source for Vitamin B-complex components such as Vitamin B12, Nicotinic Acid (Niacin), and Vitamin B6 analogs.
Historically, the FDA has regulated these substances under the category of biological products. When used as an allergenic extract, Yeast, Unspecified is utilized by healthcare providers to diagnose Type I hypersensitivity reactions (immediate-type allergies) through skin testing or to treat these allergies through subcutaneous immunotherapy (allergy shots). Beyond its role in immunology, yeast-derived compounds serve as critical nutritional substrates. Yeast is naturally rich in proteins, minerals, and vitamins, particularly the B-complex group, which are essential for cellular metabolism and neurological health.
The mechanism of action for Yeast, Unspecified depends entirely on its clinical application. When used as an allergenic extract, it works by interacting with the patient's immune system. Upon intradermal or epicutaneous (skin prick) administration, the proteins within the yeast extract cross-link with specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils. This cross-linking triggers degranulation, releasing inflammatory mediators like histamine, leukotrienes, and prostaglandins. In a diagnostic setting, this results in a 'wheal and flare' reaction (a raised bump and redness), confirming sensitization. In immunotherapy, repeated, escalating doses of the extract are administered to induce 'immune tolerance.' This process shifts the immune response from a Th2-dominated (allergic) profile to a Th1-dominated or T-regulatory (Treg) profile, increasing the production of IgG4 'blocking' antibodies that prevent the allergic cascade upon natural exposure.
When Yeast, Unspecified is utilized for its nutritional properties, it acts as a delivery vehicle for essential cofactors. For example, the Nicotinic Acid (Niacin) found in yeast is converted into Nicotinamide Adenine Dinucleotide (NAD) and Nicotinamide Adenine Dinucleotide Phosphate (NADP), which are vital for redox reactions in energy metabolism. The Vitamin B12 components are essential for DNA synthesis and the maintenance of the myelin sheath surrounding nerves. Because yeast is a complex biological organism, the 'Unspecified' designation often implies a synergistic effect of these various micronutrients working together to support systemic homeostasis.
Understanding the pharmacokinetics of Yeast, Unspecified requires distinguishing between systemic nutritional intake and localized allergenic application.
The FDA-approved and clinically recognized uses for Yeast, Unspecified products include:
Yeast, Unspecified is available in several distinct formulations depending on the therapeutic goal:
> Important: Only your healthcare provider can determine if Yeast, Unspecified is right for your specific condition. The choice between diagnostic, therapeutic, or nutritional forms must be made based on a comprehensive clinical evaluation.
Dosage for Yeast, Unspecified varies significantly based on the intended use. For Allergenic Extracts used in immunotherapy, the dosage is highly individualized. It typically begins with a 'Build-up Phase' where a very dilute concentration (e.g., 0.05 mL of a 1:100,000 w/v dilution) is administered once or twice weekly. The dose is gradually increased over 3 to 6 months until a 'Maintenance Dose' is reached, which is often 0.5 mL of a 1:100 or 1:10 w/v concentration, administered every 2 to 4 weeks.
For Nutritional Supplementation (e.g., Brewer's Yeast), the standard adult dose is typically 1 to 2 tablespoons (15-30 grams) of powder daily, or 2 to 4 tablets (500 mg each) taken up to three times per day. Because 'Yeast, Unspecified' can contain varying levels of B-vitamins, patients should follow the specific labeling on the product provided by their pharmacist.
The use of Yeast, Unspecified in children must be supervised by a specialist.
For nutritional forms of yeast, no specific dosage adjustments are usually required for mild to moderate renal impairment. However, in patients with end-stage renal disease (ESRD), the high phosphorus and potassium content of some yeast products must be considered. For allergenic extracts, renal function does not typically impact the local immune response, but caution is advised if the patient is on medications for kidney-related hypertension (like ACE inhibitors) that might complicate the management of an allergic reaction.
No dosage adjustment is generally necessary for hepatic impairment when using allergenic extracts. For nutritional supplements, patients with severe liver disease should be monitored if taking high doses of yeast-derived niacin, which can rarely be hepatotoxic in very high concentrations.
Elderly patients should start at the lower end of the dosing range. They are at a higher risk for adverse cardiovascular events if a systemic allergic reaction occurs during immunotherapy. Healthcare providers will often perform a more thorough cardiac screening before initiating treatment in patients over 65.
An overdose of Yeast, Unspecified allergenic extract can lead to Anaphylaxis, a life-threatening systemic reaction. Symptoms include difficulty breathing, swelling of the throat, rapid pulse, and a sharp drop in blood pressure. If an overdose is suspected during an injection, epinephrine must be administered immediately.
For oral supplements, an overdose may cause severe nausea, vomiting, diarrhea, or a profound 'niacin flush' (intense redness and itching of the skin). In case of accidental ingestion of large quantities, contact a Poison Control Center or seek emergency medical care.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or frequency without direct medical guidance, as this increases the risk of treatment failure or severe allergic reactions.
When using Yeast, Unspecified as an allergenic extract, the most common side effects are localized to the site of administration. These include:
For oral nutritional forms, common side effects include:
> Warning: Stop taking Yeast, Unspecified and call your doctor immediately or seek emergency services if you experience any of the following symptoms of Anaphylaxis:
With prolonged use of Yeast, Unspecified immunotherapy, some patients may develop a persistent 'nodule' or small lump under the skin at the injection site. This is typically a granuloma and is benign, though it should be monitored. Long-term use of high-dose yeast supplements containing niacin may rarely lead to changes in liver function tests or glucose intolerance (elevated blood sugar). It is important to have periodic blood work if using high doses for extended periods.
While Yeast, Unspecified itself does not always carry a specific 'Black Box' label in the same way as high-risk pharmaceuticals, the FDA-approved labeling for allergenic extracts includes a prominent warning regarding the risk of Severe Systemic Reactions.
Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients with unstable asthma are at increased risk. Extracts should only be administered by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients must be observed for at least 30 minutes following administration. Epinephrine 1:1000 must be immediately available.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.
Yeast, Unspecified products, particularly those used for allergy diagnosis and treatment, carry significant risks if not used under strict medical supervision. The most critical safety point is the potential for an immediate, life-threatening allergic reaction. Patients must never self-administer allergenic extracts at home. Furthermore, patients should be in their 'baseline' state of health before receiving an injection; having a fever, active asthma flare, or severe respiratory infection can increase the risk of a dangerous reaction.
No specific FDA black box warning exists for the generic 'Yeast, Unspecified' entry, but all allergenic extracts derived from yeast are subject to the standard class warning for allergenic products. This warning emphasizes that these products can cause anaphylaxis and should only be used in facilities capable of handling such emergencies. If you have a history of severe reactions to any fungal or yeast product, you must disclose this to your physician before any testing begins.
Yeast, Unspecified does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.
Alcohol should be avoided immediately before and after receiving an injection of Yeast, Unspecified extract, as alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a reaction. For those taking oral supplements, alcohol may worsen the 'niacin flush.'
There is no 'withdrawal syndrome' associated with Yeast, Unspecified. However, stopping immunotherapy prematurely will result in the return of allergy symptoms. If you wish to stop treatment, discuss a tapering or transition plan with your allergist.
> Important: Discuss all your medical conditions, especially respiratory and heart problems, with your healthcare provider before starting any form of Yeast, Unspecified.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications, before starting Yeast, Unspecified.
Yeast, Unspecified must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a specialist include:
Patients allergic to Yeast, Unspecified may exhibit cross-sensitivity to other fungal elements. This includes:
> Important: Your healthcare provider will evaluate your complete medical history, including your current respiratory status and medication list, before prescribing or administering Yeast, Unspecified.
Pregnancy Category C: Animal reproduction studies have not been conducted with Yeast, Unspecified extracts. It is unknown whether these extracts can cause fetal harm when administered to a pregnant woman. The primary concern during pregnancy is not the direct effect of the yeast, but the potential for maternal anaphylaxis. A severe allergic reaction can lead to maternal hypotension and uterine hypoperfusion, resulting in fetal hypoxia (lack of oxygen to the baby).
It is not known whether the allergenic proteins in Yeast, Unspecified extracts are excreted in human milk. However, most B-vitamins found in nutritional yeast are normal components of breast milk. Standard doses of nutritional yeast are generally considered safe during lactation. For immunotherapy, the risk to the nursing infant is considered negligible, but the mother should be monitored for systemic reactions as usual.
Patients over the age of 65 may have a higher prevalence of comorbid conditions (like heart disease or COPD) that make them more vulnerable to the side effects of Yeast, Unspecified extracts.
In patients with significant kidney disease, the use of yeast as a nutritional supplement must be managed carefully. Yeast is high in phosphorus and potassium, which can accumulate in the blood (hyperphosphatemia and hyperkalemia) when kidney function is impaired. For allergenic extracts, no specific dose adjustment is needed, but monitoring for blood pressure stability is essential.
For most patients with liver disease, Yeast, Unspecified is safe. However, in cases of advanced cirrhosis, the liver's ability to process high doses of niacin (nicotinic acid) may be compromised. Monitoring for jaundice or elevated liver enzymes is recommended if high-dose oral supplements are used.
> Important: Special populations require individualized medical assessment. Always inform your specialist about pregnancy status or chronic organ disease before starting treatment.
Yeast, Unspecified functions through two primary pharmacological pathways:
| Parameter | Value (Nutritional/Systemic) |
|---|---|
| Bioavailability | 60-90% (B-vitamins) |
| Protein Binding | Variable (Albumin for Niacin) |
| Half-life | 45 min (Niacin) to 6 days (B12 in liver) |
| Tmax | 1-2 hours (Oral) |
| Metabolism | Hepatic (Enzymatic phosphorylation) |
| Excretion | Renal (Primary) |
Yeast, Unspecified is categorized as a Standardized/Non-Standardized Allergenic Extract. It is related to other fungal extracts like Candida albicans and Saccharomyces cerevisiae, but the 'Unspecified' label allows for broader clinical application when specific strain identification is not required for the diagnostic or therapeutic goal.
Common questions about Yeast, Unspecified
Yeast, Unspecified is primarily used in two ways: as an allergenic extract and as a nutritional supplement. In allergy medicine, it is used for skin testing to diagnose yeast allergies and in immunotherapy (allergy shots) to help patients build tolerance to yeast allergens. Nutritionally, it serves as a rich source of B-complex vitamins, including B12, B6, and Niacin, which support energy metabolism and nervous system health. It may also be used in some specialized laboratory settings as a standardized chemical allergen. Always consult your healthcare provider to understand which form of yeast is being used for your specific treatment.
The side effects depend on how the product is used. For allergy shots or skin tests, the most common side effects are local reactions like redness, itching, and swelling at the injection site. For oral yeast supplements, common issues include digestive upset such as gas, bloating, or a 'niacin flush,' which is a temporary warming and reddening of the skin. While these are usually mild, they should be reported to a doctor if they persist. Rarely, more serious systemic reactions can occur with injections, requiring immediate medical attention.
It is generally advised to avoid alcohol when receiving Yeast, Unspecified injections for allergy treatment. Alcohol increases blood flow to the skin and can potentially speed up the absorption of the allergen, which may increase the risk of a severe systemic reaction. For those taking oral yeast supplements, alcohol can intensify the 'niacin flush' and may cause additional stomach irritation. It is best to wait at least 24 hours after an allergy injection before consuming alcohol. Always discuss your lifestyle habits with your allergist to ensure safety.
Yeast, Unspecified is classified as FDA Pregnancy Category C, meaning its safety has not been fully established through controlled human trials. The main concern during pregnancy is the risk of a severe allergic reaction (anaphylaxis) from an injection, which could deprive the fetus of oxygen. Most doctors will not start new allergy immunotherapy during pregnancy but may continue a stable maintenance dose if the benefits outweigh the risks. Oral nutritional yeast is generally considered safe in normal dietary amounts, but you should always consult your OB-GYN before starting any new supplement while pregnant.
The timeline for Yeast, Unspecified depends on the goal of treatment. For allergy diagnosis, a skin test works within 15 to 20 minutes to show a reaction. For allergy immunotherapy, it can take 6 months to a year of regular injections to notice a significant reduction in allergy symptoms. When used as a nutritional supplement to correct a vitamin deficiency, it may take several weeks of daily use before energy levels or laboratory markers improve. Consistency is key for both immunotherapy and nutritional supplementation.
You can stop taking oral yeast supplements suddenly without experiencing physical withdrawal symptoms. However, if you are using Yeast, Unspecified for allergy immunotherapy, stopping suddenly will cause your allergy symptoms to return over time as your immune tolerance fades. It is not dangerous to stop, but it will negate the progress made during the build-up phase of treatment. If you are experiencing side effects that make you want to stop, talk to your doctor about adjusting the dose instead of quitting abruptly.
If you miss a dose of an oral yeast supplement, take it as soon as you remember, unless it is nearly time for your next dose. For missed allergy injections, the protocol is more strict. Missing an injection by more than a week may require your doctor to reduce your next dose to prevent a reaction, as your body may have become more sensitive during the break. Never try to 'double up' on an allergy injection. Contact your allergist's office immediately to reschedule and determine the safe dose for your next visit.
There is no strong clinical evidence that Yeast, Unspecified causes significant weight gain. Some people may experience mild bloating or water retention when first starting oral yeast supplements, which can feel like weight gain but is usually temporary. In fact, because yeast is high in protein and B-vitamins that support metabolism, it is sometimes used as part of a weight management plan. However, if you notice rapid or unusual weight gain, you should consult your healthcare provider to rule out other underlying medical conditions.
Yeast, Unspecified can interact with several types of medications. The most serious interaction is with beta-blockers, which can make it difficult to treat an allergic reaction if one occurs. It can also interact with MAO inhibitors (antidepressants) due to the tyramine content in yeast, potentially causing a dangerous spike in blood pressure. Antihistamines will interfere with allergy skin tests, making them appear negative even if you are allergic. Always provide your doctor with a full list of your current medications before starting any yeast-based product.
The term 'Yeast, Unspecified' itself refers to a generic category of biological products rather than a specific brand-name drug. Many different manufacturers produce yeast extracts and supplements under various labels, such as 'Brewer's Yeast' or 'Allergenic Extract, Yeast.' Because these are biological products, they are not 'generic' in the same way as a chemical pill like ibuprofen, but many affordable versions are available. Your pharmacist or allergist can help you select a high-quality product that meets the standards for your specific medical needs.